| 标题 |
Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjögren’s syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of the Rheumatic Diseases 作者:Thomas Dörner; Martin Kaul; Antónia Szántó; Jui-Cheng Tseng; Athena Papas; et al 出版日期:2023-11-06 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)